New Drug Candidate Prolongs The Lives Of Pancreatic Cancer Patients
Links shared publicly online about this topic.
The new drug compound Salirasib has shown positive results against pancreatic cancer and recently passed Phase I/II clinical trials. The drug, given in combination with gemcitabine, the standard drug used to combat pancreatic cancer, almost doubled the life expectancy of those who received it. View full resource at sciencedaily.com
Tags: Pancreatic Disease, Cancer, Cancer Medication, Pancreatic Cancer, Drug, Clinical Trial, Gemzar
Most Recently Shared on November 5, 2009 at 8:15 pm By:
physorg.com — “Every year, 42,000 Americans are diagnosed with pancreatic cancer. Few live very long, and less than 5% are still alive five years after diagnosis.” View full resource at physorg.com
Most Recently Shared on July 20, 2009 at 4:45 pm By: